{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:41:57Z","timestamp":1791549717351,"version":"4.3.4"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T00:00:00Z","timestamp":1677715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C10847\/A27781"],"award-info":[{"award-number":["C10847\/A27781"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","award":["2017NovPR988"],"award-info":[{"award-number":["2017NovPR988"]}],"id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. Virtually all women with DCIS are treated, despite evidence suggesting up to half would remain with stable, non-threatening, disease. Overtreatment thus presents a pressing issue in DCIS management. To understand the role of the normally tumour suppressive myoepithelial cell in disease progression we present a 3D in vitro model incorporating both luminal and myoepithelial cells in physiomimetic conditions. We demonstrate that DCIS-associated myoepithelial cells promote striking myoepithelial-led invasion of luminal cells, mediated by the collagenase MMP13 through a non-canonical TGF\u03b2 \u2013 EP300 pathway. In vivo, MMP13 expression is associated with stromal invasion in a murine model of DCIS progression and is elevated in myoepithelial cells of clinical high-grade DCIS cases. Our data identify a key role for myoepithelial-derived MMP13 in facilitating DCIS progression and point the way towards a robust marker for risk stratification in DCIS patients.<\/jats:p>","DOI":"10.1038\/s41523-023-00513-6","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T05:02:32Z","timestamp":1677733352000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["TGF\u03b2-mediated MMP13 secretion drives myoepithelial cell dependent breast cancer progression"],"prefix":"10.1038","volume":"9","author":[{"given":"Shayin V.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7897-8891","authenticated-orcid":false,"given":"Elena","family":"Tomas Bort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Rodr\u00edguez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2121-8087","authenticated-orcid":false,"given":"Michael D.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer J.","family":"Gomm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Goulding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"auf dem Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Agnoletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6857-3230","authenticated-orcid":false,"given":"Cathrin","family":"Brisken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-8495","authenticated-orcid":false,"given":"Barrie","family":"Peck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus J.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3880-3274","authenticated-orcid":false,"given":"J. Louise","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4499-1101","authenticated-orcid":false,"given":"Edward P.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4738-0173","authenticated-orcid":false,"given":"Richard P.","family":"Grose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,2]]},"reference":[{"key":"513_CR1","unstructured":"CancerResearchUK. Breast Cancer Statistics 2020 [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/breast-cancer."},{"key":"513_CR2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/jnci\/djp485","volume":"102","author":"CJ Allegra","year":"2010","unstructured":"Allegra, C. J. et al. National institutes of health state-of-the-science conference statement: diagnosis and management of ductal carcinoma in situ September 22-24, 2009. J. Natl. Cancer Inst. 102, 161\u2013169 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"513_CR3","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1002\/cncr.21069","volume":"103","author":"ME Sanders","year":"2005","unstructured":"Sanders, M. E., Schuyler, P. A., Dupont, W. D. & Page, D. L. The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up. Cancer 103, 2481\u20132484 (2005).","journal-title":"Cancer"},{"key":"513_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.7150\/jca.2.232","volume":"2","author":"SA Lari","year":"2011","unstructured":"Lari, S. A. & Kuerer, H. M. Biological markers in DCIS and risk of breast recurrence: a systematic review. J. Cancer 2, 232\u2013261 (2011).","journal-title":"J. Cancer"},{"key":"513_CR5","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/jnci\/djq161","volume":"102","author":"NJ Nelson","year":"2010","unstructured":"Nelson, N. J. DCIS prognostic markers: a few new candidates emerge. J. Natl. Cancer Inst. 102, 588\u2013590 (2010).","journal-title":"J. Natl. Cancer Inst."},{"key":"513_CR6","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1016\/S0140-6736(12)61611-0","volume":"380","author":"Independent UKPoBCS.","year":"2012","unstructured":"Independent UKPoBCS. The benefits and harms of breast cancer screening: an independent review. Lancet. 380, 1778\u20131786 (2012).","journal-title":"Lancet."},{"key":"513_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.trecan.2019.05.005","volume":"5","author":"CL van der Borden","year":"2019","unstructured":"van der Borden, C. L., Stoffers, S., Lips, E. H. & Wesseling, J. Avoiding overtreatment of ductal carcinoma in situ. Trends Cancer 5, 391\u2013393 (2019).","journal-title":"Trends Cancer"},{"key":"513_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2157","volume":"10","author":"NP Castro","year":"2008","unstructured":"Castro, N. P. et al. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Breast Cancer Res. 10, R87 (2008).","journal-title":"Breast Cancer Res."},{"key":"513_CR9","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1073\/pnas.0931261100","volume":"100","author":"XJ Ma","year":"2003","unstructured":"Ma, X. J. et al. Gene expression profiles of human breast cancer progression. Proc. Natl. Acad. Sci. USA. 100, 5974\u20135979 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"513_CR10","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/sj.bjc.6606021","volume":"104","author":"SE Clark","year":"2011","unstructured":"Clark, S. E. et al. Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease. Br. J. Cancer 104, 120\u2013127 (2011).","journal-title":"Br. J. Cancer"},{"key":"513_CR11","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cell.2017.12.007","volume":"172","author":"AK Casasent","year":"2018","unstructured":"Casasent, A. K. et al. Multiclonal invasion in breast tumors identified by topographic single cell sequencing. Cell 172, 205\u2013217 (2018).","journal-title":"Cell"},{"key":"513_CR12","doi-asserted-by":"crossref","unstructured":"Gibson SV, et al. Everybody needs good neighbours: the progressive DCIS microenvironment. Trends Cancer S2405\u20138033, 00002-X. (2023) Epub ahead of print.","DOI":"10.1016\/j.trecan.2023.01.002"},{"key":"513_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.ccr.2004.06.010","volume":"6","author":"M Allinen","year":"2004","unstructured":"Allinen, M. et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 6, 17\u201332 (2004).","journal-title":"Cancer Cell"},{"key":"513_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10549-009-0654-0","volume":"123","author":"M Sharma","year":"2010","unstructured":"Sharma, M. et al. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res. Treat. 123, 397\u2013404 (2010).","journal-title":"Breast Cancer Res. Treat."},{"key":"513_CR15","first-page":"4763","volume":"42","author":"BA Gusterson","year":"1982","unstructured":"Gusterson, B. A. et al. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. Cancer Res. 42, 4763\u20134770 (1982).","journal-title":"Cancer Res"},{"key":"513_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/bcr1286","volume":"7","author":"MC Adriance","year":"2005","unstructured":"Adriance, M. C., Inman, J. L., Petersen, O. W. & Bissell, M. J. Myoepithelial cells: good fences make good neighbors. Breast Cancer Res. 7, 190\u2013197 (2005).","journal-title":"Breast Cancer Res"},{"key":"513_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s10911-005-9586-4","volume":"10","author":"T Gudjonsson","year":"2005","unstructured":"Gudjonsson, T., Adriance, M. C., Sternlicht, M. D., Petersen, O. W. & Bissell, M. J. Myoepithelial cells: their origin and function in breast morphogenesis and neoplasia. J. Mammary Gland Biol. Neopl. 10, 261\u2013272 (2005).","journal-title":"J. Mammary Gland Biol. Neopl."},{"key":"513_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0014-4800(03)00011-X","volume":"74","author":"SH Barsky","year":"2003","unstructured":"Barsky, S. H. Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype. Exp. Mol. Pathol. 74, 113\u2013122 (2003).","journal-title":"Exp. Mol. Pathol."},{"key":"513_CR19","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1006\/excr.1998.4066","volume":"241","author":"ZM Shao","year":"1998","unstructured":"Shao, Z. M., Nguyen, M., Alpaugh, M. L., O\u2019Connell, J. T. & Barsky, S. H. The human myoepithelial cell exerts antiproliferative effects on breast carcinoma cells characterized by p21WAF1\/CIP1 induction, G2\/M arrest, and apoptosis. Exp. Cell Res. 241, 394\u2013403 (1998).","journal-title":"Exp. Cell Res."},{"key":"513_CR20","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1126\/science.8290962","volume":"263","author":"Z Zou","year":"1994","unstructured":"Zou, Z. et al. Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263, 526\u2013529 (1994).","journal-title":"Science"},{"key":"513_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/ncb0901-823","volume":"3","author":"SK Runswick","year":"2001","unstructured":"Runswick, S. K., O\u2019Hare, M. J., Jones, L., Streuli, C. H. & Garrod, D. R. Desmosomal adhesion regulates epithelial morphogenesis and cell positioning. Nat. Cell Biol. 3, 823\u2013830 (2001).","journal-title":"Nat. Cell Biol."},{"key":"513_CR22","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1002\/mc.23171","volume":"59","author":"E Mitchell","year":"2020","unstructured":"Mitchell, E. et al. Loss of myoepithelial calponin-1 characterizes high-risk ductal carcinoma in situ cases, which are further stratified by T cell composition. Mol. Carcinog. 59, 701\u2013712 (2020).","journal-title":"Mol. Carcinog."},{"key":"513_CR23","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10911-005-9584-6","volume":"10","author":"K Polyak","year":"2005","unstructured":"Polyak, K. & Hu, M. Do myoepithelial cells hold the key for breast tumor progression? J. Mammary Gland Biol. Neopl. 10, 231\u2013247 (2005).","journal-title":"J. Mammary Gland Biol. Neopl."},{"key":"513_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/1078-0432.CCR-13-1504","volume":"20","author":"MD Allen","year":"2014","unstructured":"Allen, M. D. et al. Altered microenvironment promotes progression of preinvasive breast cancer: myoepithelial expression of alphavbeta6 integrin in DCIS identifies high-risk patients and predicts recurrence. Clin. Cancer Res. 20, 344\u2013357 (2014).","journal-title":"Clin. Cancer Res."},{"key":"513_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1242\/jcs.115.1.39","volume":"115","author":"T Gudjonsson","year":"2002","unstructured":"Gudjonsson, T. et al. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J. Cell Sci. 115, 39\u201350 (2002).","journal-title":"J. Cell Sci."},{"key":"513_CR26","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2021.12.023","volume":"185","author":"T Risom","year":"2022","unstructured":"Risom, T. et al. Transition to invasive breast cancer is associated with progressive changes in the structure and composition of tumor stroma. Cell 185, 299\u2013310 (2022).","journal-title":"Cell"},{"key":"513_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00464-4","volume":"8","author":"M-K Hayward","year":"2022","unstructured":"Hayward, M.-K. et al. Mechanostimulation of breast myoepithelial cells induces functional changes associated with DCIS progression to invasion. npj Breast Cancer 8, 109 (2022).","journal-title":"npj Breast Cancer"},{"key":"513_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes, R. O. Integrins: bidirectional, allosteric signaling machines. Cell 110, 673\u2013687 (2002).","journal-title":"Cell"},{"key":"513_CR29","doi-asserted-by":"publisher","first-page":"100023","DOI":"10.1016\/j.gene.2019.100023","volume":"763S","author":"A Meecham","year":"2020","unstructured":"Meecham, A. & Marshall, J. F. The ITGB6 gene: its role in experimental and clinical biology. Gene 763S, 100023 (2020).","journal-title":"Gene"},{"key":"513_CR30","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2174\/138945009788680374","volume":"10","author":"A Bandyopadhyay","year":"2009","unstructured":"Bandyopadhyay, A. & Raghavan, S. Defining the role of integrin \u03b1v\u03b26 in cancer. Curr. Drug Targets 10, 645\u2013652 (2009).","journal-title":"Curr. Drug Targets"},{"key":"513_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13058-017-0843-4","volume":"19","author":"EP Carter","year":"2017","unstructured":"Carter, E. P., Gopsill, J. A., Gomm, J. J., Jones, J. L. & Grose, R. P. A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer. Breast Cancer Res. 19, 1\u201310 (2017).","journal-title":"Breast Cancer Res."},{"key":"513_CR32","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1073\/pnas.88.9.3520","volume":"88","author":"J Bartek","year":"1991","unstructured":"Bartek, J. et al. Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. Proc. Natl. Academy Sci. 88, 3520\u20133524 (1991).","journal-title":"Proc. Natl. Academy Sci."},{"key":"513_CR33","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1002\/ijc.23925","volume":"123","author":"O De Wever","year":"2008","unstructured":"De Wever, O., Demetter, P., Mareel, M. & Bracke, M. Stromal myofibroblasts are drivers of invasive cancer growth. Int. J. Cancer 123, 2229\u20132238 (2008).","journal-title":"Int. J. Cancer"},{"key":"513_CR34","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/pin.12391","volume":"66","author":"X Wang","year":"2016","unstructured":"Wang, X., Enomoto, A., Asai, N., Kato, T. & Takahashi, M. Collective invasion of cancer: perspectives from pathology and development. Pathol. Int. 66, 183\u2013192 (2016).","journal-title":"Pathol. Int."},{"key":"513_CR35","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1016\/j.cell.2013.11.029","volume":"155","author":"KJ Cheung","year":"2013","unstructured":"Cheung, K. J., Gabrielson, E., Werb, Z. & Ewald, A. J. Collective invasion in breast cancer requires a conserved basal epithelial program. Cell 155, 1639\u20131651 (2013).","journal-title":"Cell"},{"key":"513_CR36","doi-asserted-by":"publisher","first-page":"E2595","DOI":"10.1073\/pnas.1212834109","volume":"109","author":"K-V Nguyen-Ngoc","year":"2012","unstructured":"Nguyen-Ngoc, K.-V. et al. ECM microenvironment regulates collective migration and local dissemination in normal and malignant mammary epithelium. Proc. Natl. Acad. Sci. 109, E2595\u2013E2604 (2012).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"513_CR37","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/ncb2548","volume":"14","author":"P Friedl","year":"2012","unstructured":"Friedl, P., Locker, J., Sahai, E. & Segall, J. E. Classifying collective cancer cell invasion. Nat. Cell Biol. 14, 777\u2013783 (2012).","journal-title":"Nat. Cell Biol."},{"key":"513_CR38","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/ncb3478","volume":"19","author":"A Labernadie","year":"2017","unstructured":"Labernadie, A. et al. A mechanically active heterotypic E-cadherin\/N-cadherin adhesion enables fibroblasts to drive cancer cell invasion. Nat. Cell Biol. 19, 224\u2013237 (2017).","journal-title":"Nat. Cell Biol."},{"key":"513_CR39","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1083\/jcb.201903066","volume":"218","author":"J Chang","year":"2019","unstructured":"Chang, J. & Chaudhuri, O. Beyond proteases: basement membrane mechanics and cancer invasion. J. Cell Biol. 218, 2456\u20132469 (2019).","journal-title":"J. Cell Biol."},{"key":"513_CR40","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1083\/jcb.201210152","volume":"201","author":"K Wolf","year":"2013","unstructured":"Wolf, K. et al. Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force. J. Cell Biol. 201, 1069\u20131084 (2013).","journal-title":"J. Cell Biol."},{"key":"513_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chembiol.2004.11.014","volume":"12","author":"CK Engel","year":"2005","unstructured":"Engel, C. K. et al. Structural basis for the highly selective inhibition of MMP-13. Chem. Biol. 12, 181\u2013189 (2005).","journal-title":"Chem. Biol."},{"key":"513_CR42","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1083\/jcb.200312172","volume":"165","author":"JP Annes","year":"2004","unstructured":"Annes, J. P., Chen, Y., Munger, J. S. & Rifkin, D. B. Integrin \u03b1V\u03b26-mediated activation of latent TGF-\u03b2 requires the latent TGF-\u03b2 binding protein-1. J. Cell Biol. 165, 723\u2013734 (2004).","journal-title":"J. Cell Biol."},{"key":"513_CR43","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature10152","volume":"474","author":"M Shi","year":"2011","unstructured":"Shi, M. et al. Latent TGF-\u03b2 structure and activation. Nature 474, 343\u2013349 (2011).","journal-title":"Nature"},{"key":"513_CR44","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s10555-005-5131-6","volume":"24","author":"D Sheppard","year":"2005","unstructured":"Sheppard, D. Integrin-mediated activation of latent transforming growth factor \u03b2. Cancer Metastasis Rev. 24, 395\u2013402 (2005).","journal-title":"Cancer Metastasis Rev."},{"key":"513_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-018-0602-x","volume":"10","author":"W Tang","year":"2018","unstructured":"Tang, W. et al. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival. Genome Med. 10, 1\u201314 (2018).","journal-title":"Genome Med."},{"key":"513_CR46","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.ccell.2016.02.002","volume":"29","author":"G Sflomos","year":"2016","unstructured":"Sflomos, G. et al. A preclinical model for ER\u03b1-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response. Cancer Cell 29, 407\u2013422 (2016).","journal-title":"Cancer Cell"},{"key":"513_CR47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-56847-4","volume":"10","author":"X-L Luo","year":"2020","unstructured":"Luo, X.-L. et al. Development and characterization of mammary intraductal (MIND) spontaneous metastasis models for triple-negative breast cancer in syngeneic mice. Sci. Rep. 10, 1\u201311 (2020).","journal-title":"Sci. Rep."},{"key":"513_CR48","doi-asserted-by":"publisher","first-page":"dju169","DOI":"10.1093\/jnci\/dju169","volume":"106","author":"KM Moore","year":"2014","unstructured":"Moore, K. M. et al. Therapeutic targeting of integrin \u03b1v\u03b26 in breast cancer. J. Natl. Cancer Inst. 106, dju169 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"513_CR49","first-page":"4882","volume":"57","author":"JA Ur\u00eda","year":"1997","unstructured":"Ur\u00eda, J. A., St\u00e5hle-B\u00e4ckdahl, M., Seiki, M., Fueyo, A. & L\u00f3pez-Ot\u00edn, C. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions. Cancer Res. 57, 4882\u20134888 (1997).","journal-title":"Cancer Res."},{"key":"513_CR50","first-page":"7091","volume":"61","author":"BS Nielsen","year":"2001","unstructured":"Nielsen, B. S. et al. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Cancer Res. 61, 7091\u20137100 (2001).","journal-title":"Cancer Res."},{"key":"513_CR51","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","volume":"173","author":"KA Hoadley","year":"2018","unstructured":"Hoadley, K. A. et al. Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell 173, 291\u2013304 (2018).","journal-title":"Cell"},{"key":"513_CR52","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/BF02967183","volume":"7","author":"K Arihiro","year":"2000","unstructured":"Arihiro, K., Kaneko, M., Fujii, S., Inai, K. & Yokosaki, Y. Significance of \u03b19\u03b21 and \u03b1v\u03b26 integrin expression in breast carcinoma. Breast Cancer 7, 19\u201326 (2000).","journal-title":"Breast Cancer"},{"key":"513_CR53","doi-asserted-by":"publisher","first-page":"821","DOI":"10.2217\/14796694.1.6.821","volume":"1","author":"RC Bates","year":"2005","unstructured":"Bates, R. C. The \u03b1v\u03b26 integrin as a novel molecular target for colorectal cancer. Future Oncol. 1, 821\u2013828 (2005).","journal-title":"Future Oncol."},{"key":"513_CR54","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/path.5320","volume":"249","author":"CS Reader","year":"2019","unstructured":"Reader, C. S. et al. The integrin \u03b1v\u03b26 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy. J. Pathol. 249, 332\u2013342 (2019).","journal-title":"J. Pathol."},{"key":"513_CR55","doi-asserted-by":"publisher","first-page":"41646","DOI":"10.1074\/jbc.M306274200","volume":"278","author":"X Li","year":"2003","unstructured":"Li, X. et al. \u03b1v\u03b26-Fyn signaling promotes oral cancer progression. J. Biol. Chem. 278, 41646\u201341653 (2003).","journal-title":"J. Biol. Chem."},{"key":"513_CR56","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/sj.bjc.6600545","volume":"87","author":"GJ Thomas","year":"2002","unstructured":"Thomas, G. J., Hart, I. R., Speight, P. M. & Marshall, J. F. Binding of TGF-\u03b21 latency-associated peptide (LAP) to \u03b1v\u03b26 integrin modulates behaviour of squamous carcinoma cells. Br. J. Cancer 87, 859\u2013867 (2002).","journal-title":"Br. J. Cancer"},{"key":"513_CR57","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.trecan.2021.06.009","volume":"7","author":"EP Carter","year":"2021","unstructured":"Carter, E. P., Roozitalab, R., Gibson, S. V. & Grose, R. P. Tumour microenvironment 3D-modelling: Simplicity to complexity and back again. Trends Cancer 7, 1033\u20131046 (2021).","journal-title":"Trends Cancer"},{"key":"513_CR58","first-page":"89","volume":"62","author":"J DiRenzo","year":"2002","unstructured":"DiRenzo, J. et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res. 62, 89\u201398 (2002).","journal-title":"Cancer Res."},{"key":"513_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-10-30","volume":"10","author":"R Yusuf","year":"2010","unstructured":"Yusuf, R. & Frenkel, K. Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen\/epidermal growth factor receptors. Cancer Cell Int. 10, 1\u201316 (2010).","journal-title":"Cancer Cell Int."},{"key":"513_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41568-019-0238-1","volume":"20","author":"E Sahai","year":"2020","unstructured":"Sahai, E. et al. A framework for advancing our understanding of cancer-associated fibroblasts. Nat. Rev. Cancer 20, 174\u2013186 (2020).","journal-title":"Nat. Rev. Cancer"},{"key":"513_CR61","doi-asserted-by":"publisher","first-page":"e00085","DOI":"10.1042\/BSR20130060","volume":"33","author":"MA Folgueira","year":"2013","unstructured":"Folgueira, M. A. et al. Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series. Biosci. Rep. 33, e00085 (2013).","journal-title":"Biosci. Rep."},{"key":"513_CR62","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1158\/1078-0432.CCR-0398-3","volume":"10","author":"S Porter","year":"2004","unstructured":"Porter, S. et al. Dysregulated expression of adamalysin-thrombospondin genes in human breast carcinoma. Clin. Cancer Res. 10, 2429\u20132440 (2004).","journal-title":"Clin. Cancer Res."},{"key":"513_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-017-0822-9","volume":"19","author":"M Sarper","year":"2017","unstructured":"Sarper, M. et al. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function. Breast Cancer Res. 19, 33 (2017).","journal-title":"Breast Cancer Res."},{"key":"513_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nrc2853","volume":"10","author":"H Ikushima","year":"2010","unstructured":"Ikushima, H. & Miyazono, K. TGFbeta signalling: a complex web in cancer progression. Nat. Rev. Cancer 10, 415\u2013424 (2010).","journal-title":"Nat. Rev. Cancer"},{"key":"513_CR65","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1158\/1078-0432.CCR-0320-03","volume":"10","author":"MB Buck","year":"2004","unstructured":"Buck, M. B., Fritz, P., Dippon, J., Zugmaier, G. & Knabbe, C. Prognostic significance of transforming growth factor \u03b2 receptor II in estrogen receptor-negative breast cancer patients. Clin. Cancer Res. 10, 491\u2013498 (2004).","journal-title":"Clin. Cancer Res."},{"key":"513_CR66","first-page":"381","volume":"143","author":"BI Dalal","year":"1993","unstructured":"Dalal, B. I., Keown, P. A. & Greenberg, A. H. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma. Am. J. Pathol. 143, 381 (1993).","journal-title":"Am. J. Pathol."},{"key":"513_CR67","doi-asserted-by":"publisher","first-page":"38014","DOI":"10.1074\/jbc.M110.142141","volume":"285","author":"M Lee","year":"2010","unstructured":"Lee, M. & Partridge, N. C. Parathyroid hormone activation of matrix metalloproteinase-13 transcription requires the histone acetyltransferase activity of p300 and PCAF and p300-dependent acetylation of PCAF. J. Biol. Chem. 285, 38014\u201338022 (2010).","journal-title":"J. Biol. Chem."},{"key":"513_CR68","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1210\/me.2008-0217","volume":"23","author":"CE Boumah","year":"2009","unstructured":"Boumah, C. E., Lee, M., Selvamurugan, N., Shimizu, E. & Partridge, N. C. Runx2 recruits p300 to mediate parathyroid hormone\u2019s effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene. Mol. Endocrinol. 23, 1255\u20131263 (2009).","journal-title":"Mol. Endocrinol."},{"key":"513_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/(SICI)1097-4652(199704)171:1<11::AID-JCP2>3.0.CO;2-K","volume":"171","author":"JJ Gomm","year":"1997","unstructured":"Gomm, J. J., Coope, R. C., Browne, P. J. & Coombes, R. C. Separated human breast epithelial and myoepithelial cells have different growth factor requirements in vitro but can reconstitute normal breast lobuloalveolar structure. J Cell. Physiol. 171, 11\u201319 (1997).","journal-title":"J Cell. Physiol."},{"key":"513_CR70","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/abio.1995.1196","volume":"226","author":"JJ Gomm","year":"1995","unstructured":"Gomm, J. J. et al. Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads. Anal. Biochem. 226, 91\u201399 (1995).","journal-title":"Anal. Biochem."},{"key":"513_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms7927","volume":"6","author":"WC Hines","year":"2015","unstructured":"Hines, W. C., Yaswen, P. & Bissell, M. J. Modelling breast cancer requires identification and correction of a critical cell lineage-dependent transduction bias. Nat. Commun. 6, 1\u201311 (2015).","journal-title":"Nat. Commun."},{"key":"513_CR72","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak, K. J. & Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402\u2013408 (2001).","journal-title":"Methods"},{"key":"513_CR73","doi-asserted-by":"publisher","first-page":"e0157022","DOI":"10.1371\/journal.pone.0157022","volume":"11","author":"H Varet","year":"2016","unstructured":"Varet, H., Brillet-Gu\u00e9guen, L., Copp\u00e9e, J.-Y. & Dillies, M.-A. SARTools: a DESeq2-and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data. PloS one 11, e0157022 (2016).","journal-title":"PloS one"},{"key":"513_CR74","doi-asserted-by":"publisher","first-page":"3251","DOI":"10.1093\/bioinformatics\/btm369","volume":"23","author":"A Subramanian","year":"2007","unstructured":"Subramanian, A., Kuehn, H., Gould, J., Tamayo, P. & Mesirov, J. P. GSEA-P: a desktop application for Gene Set Enrichment Analysis. Bioinformatics 23, 3251\u20133253 (2007).","journal-title":"Bioinformatics"},{"key":"513_CR75","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in ingenuity pathway analysis. Bioinformatics. 30, 523\u2013530 (2014).","journal-title":"Bioinformatics."},{"key":"513_CR76","doi-asserted-by":"publisher","first-page":"e202001064","DOI":"10.1083\/jcb.202001064","volume":"219","author":"SJ Lord","year":"2020","unstructured":"Lord, S. J., Velle, K. B., Mullins, R. D. & Fritz-Laylin, L. K. Reproducibility: superplots: communicating reproducibility and variability in cell biology. J. Cell Biol. 219, e202001064 (2020).","journal-title":"J. Cell Biol."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-023-00513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-023-00513-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-023-00513-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T06:04:32Z","timestamp":1677737072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-023-00513-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,2]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["513"],"URL":"https:\/\/doi.org\/10.1038\/s41523-023-00513-6","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,2]]},"assertion":[{"value":"28 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}